Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Europe Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032 Europe Esoteric Testing Market is valued approximately at USD 7.06 Billion in 2023 and is anticipated to ... Read More
-
Tuberculosis Therapeutics
... at a CAGR of 2.7% over the analysis period 2023-2030. Active TB Therapeutics, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end ... Read More
-
Global Japanese Encephalitis Virus Vaccine Market Research Report 2024(Status and Outlook)
... million in 2023 and is projected to reach USD 573.40 million by 2029, exhibiting a CAGR of 5.30% during the forecast period. This report provides a deep insight into the global Japanese Encephalitis Virus Vaccine ... Read More
-
2024 Global Ophthalmic Goods, Other Types, Including Prescription Ground Eyeglass Lenses Products Markets (2030 Outlook)
... data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a ... Read More
-
Global Narcolepsy Drugs Market Report by Therapeutic Type (Sodium Oxybate, Central Nervous Systems Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Others) Disease Type (Cataplexia, Daytime Extreme Sleepiness, Other Disease type) End Users (Hospitals, Diagnostics Centers, Others) Countries and Company Analysis, 2024-2032
... Others) Countries and Company Analysis, 2024-2032 Narcolepsy Drugs Market Analysis Narcolepsy drugs market is predicted to be over US$ 6,947 million through 2032 from US$ 3,471. 3 million in 2023. It demonstrates a compound annual ... Read More
-
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032
... User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032 The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, ... Read More
-
Sepsis Therapeutics
... at a CAGR of 6.5% over the analysis period 2023-2030. Cephalosporin Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Cancer / Tumor Profiling
... reach US$19.8 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Doxorubicin
... of 5.8% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis ... Read More
-
Radiation Therapy Equipment
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More
-
Respiratory Inhalers
... at a CAGR of 6.0% over the analysis period 2023-2030. Manual Respiratory Inhalers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$54.4 Billion by the end ... Read More
-
Foot Care Products
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by ... Read More
-
Neuromodulation
... of 9.1% over the analysis period 2023-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More
-
Contraceptives
... of 6.2% over the analysis period 2023-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$26.0 Billion by the end of the analysis period. ... Read More
-
Orthopedic Prosthetic Implants
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.9 Billion by ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Cystic Fibrosis Therapeutics
... by 2030, growing at a CAGR of 15.1% over the analysis period 2023-2030. Cystic Fibrosis Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion ... Read More
-
Pancreatic Cancer Drugs
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Exocrine Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.2 Billion by ... Read More
-
Vertebral Compression Fracture Devices
... reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Prenatal Diagnostics
... at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Kidney Cancer Drugs
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.6 Billion by ... Read More
Research Assistance
